Pinealon
Low EvidenceA short bioregulatory peptide studied for neuroprotective effects and cognitive support in aging.
What It Is
Pinealon (Glu-Asp-Arg / EDR) is a synthetic tripeptide developed by the Khavinson Peptide Institute in St. Petersburg, Russia, designed to mimic the regulatory effects of pineal gland extracts on circadian function and neuroprotection. It belongs to the class of bioregulatory peptides — short synthetic peptides based on the theory that specific di- and tripeptide sequences can interact with DNA promoter regions to regulate gene expression. In preclinical studies, pinealon has been shown to increase melatonin synthesis in pinealocyte cultures, modulate serotonin metabolism, and demonstrate neuroprotective effects against oxidative stress-induced neuronal damage. Cell culture studies have reported that pinealon reduces neuronal apoptosis and improves cell viability under oxidative stress conditions. The bioregulatory peptide theory, while supported by in vitro data from the Khavinson group, has not been independently validated in large-scale studies, and the proposed mechanism of direct DNA interaction by short peptides remains controversial in the broader scientific community. No human clinical trials with rigorous placebo-controlled methodology have been published for pinealon. It is not FDA-approved and remains strictly a research compound.
Why Researchers Study It
Pinealon exemplifies the Khavinson hypothesis that short peptides can selectively restore organ function when derived from that organ's tissue. As a pineal-origin peptide, it is studied for potential regulatory effects on circadian rhythms, melatonin production, and neuroprotection via epigenetic mechanisms.
Proposed Mechanisms
- Proposed DNA-binding peptide that modulates gene expression in brain and pineal tissue
- May restore age-related decline in pineal function and melatonin signaling
- Neuroprotective effects possibly mediated through antioxidant gene upregulation
- Part of the bioregulatory peptide model alongside Thymalin and Epithalon
Evidence Snapshot
Commonly Discussed Benefits
Safety & Cautions
- Research primarily from Russian laboratories
- Limited independent replication
- No Western clinical trials
- Not FDA-approved
Comparisons
See how Pinealon compares to related peptides:
Calculator Tools
Use our research tools to explore dosing and reconstitution data:
Citations
- [1] Khavinson VK. et al. — Short peptides and gene expression. Bull Exp Biol Med. 2006 PubMed
Continue Your Research
Track your research notes and set reminders in the companion app.
Related Peptides
Semax
Medium EvidenceA synthetic peptide derived from ACTH, studied for cognitive enhancement and neuroprotective effects.
Epithalon
Low EvidenceA tetrapeptide studied for its potential to activate telomerase and influence biological aging markers.
Cerebrolysin
Medium EvidenceA porcine brain-derived peptide mixture approved in some countries for stroke recovery and neurodegenerative conditions.
Thymalin
Low EvidenceA thymic peptide preparation studied for immune system rejuvenation and age-related immune decline.